))
Inside the FDA’s Bold Elsa AI Move: Rajeev Ronanki Explains
Manage episode 490774484 series 3546701
Content provided by xCures. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by xCures or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.
100 episodes
Share
